Journal: Frontiers in Veterinary Science
Article Title: Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 Immunosuppression
doi: 10.3389/fvets.2021.656715
Figure Lengend Snippet: Effect of TGF-β1 on Th1 cytokine production and Tregs differentiation in PBMC cultures. (A) IL-2, (B) IFN-γ, and (C) TNF-α concentrations in cell culture supernatant were measured by ELISA. (D) The percentage of CD25 + Foxp3 + cells among CD4 + lymphocytes was measured by flow cytometry. The Wilcoxon signed-rank sum test was used for statistical analysis ( n = 6, * p <0.05).
Article Snippet: Subsequently, 1 μg/mL of anti-canine CD4 mouse monoclonal antibody (R&D systems) and 1 μg/mL phycoerythrin (PE)-conjugated anti-canine CD25 mouse monoclonal antibody (Thermo Fisher Scientific) were added and incubated at 25°C for 30 min.
Techniques: Cell Culture, Enzyme-linked Immunosorbent Assay, Flow Cytometry